Investors & Media

Investor Relations Home

Corporate Profile The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desi... More >>

Webcast Q2 2010 The Medicines Company Earnings Conference Call (Replay) 07/28/10 at 8:30 a.m. ET Q2 2010 The Medicines Company Earnings Conference Call Wednesday, July 28, 2010 8:30 a.m. ET   Webcast Presentation Help   Click here for webcast Add to Calendar Help  Click here to add this event to your calendar Stock Quote MDCO (Common Stock) Exchange NASDAQ (US Dollar) Price $9.21 Change (%)   0.03 (0.33%) Volume 553,668 Data as of 07/30/10 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Date Title   07/28/10 The Medicines Company Reports Second Quarter 2010 Financial Results Top Line Growth, Development Portfolio Progress and Strong Net Operating Performance PARSIPPANY, NJ, Jul 28, 2010 (MARKETWIRE via COMTEX) --The Medicines Company (NASDAQ: MDCO) today announced its financial results for the second quarter of 2010. Financial highlights for the second quarter of 2010: -- Net revenue increased to $110.1 million for the second quarter from $104.2 million for the second quarter 2009. -- Angiomax U.S. sales increased to $104.4 million compare...  07/14/10 The Medicines Company to Announce Second Quarter 2010 Financial Results on Wednesday, July 28, 2010 Conference Call to Be Held at 8:30 a.m. Eastern Time PARSIPPANY, NJ, Jul 14, 2010 (MARKETWIRE via COMTEX) --The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, July 28, 2010 at 8:30 a.m. Eastern Time to discuss second quarter 2010 financial results and operational developments. The conference call will be available via phone and webcast. The dial in information is listed below: Domestic Dial In: 866.362.5158 Int...  05/21/10 The Medicines Company Provides PTO Litigation Update PARSIPPANY, NJ, May 21, 2010 (MARKETWIRE via COMTEX) --The Medicines Company (NASDAQ: MDCO) today announced that the U.S. District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S. Patent and Trademark Office (the "PTO"), the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services. The Company's lawsuit is seeking to set aside the PTO's denial of the Company's Hatch-Waxman application to extend the principal ...  05/19/10 The Medicines Company to Participate in the 2010 Citi Global Health Care Conference PARSIPPANY, NJ, May 19, 2010 (MARKETWIRE via COMTEX) --The Medicines Company (NASDAQ: MDCO) will present at the 2010 Citi Global Health Care Conference on Wednesday , May 26th, in New York, beginning at 11am Eastern Time. Clive Meanwell, Chairman and Chief Executive Officer, will provide a company overview and outlook in the presentation. The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com under "Events." About The Me...

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever The Medicines Company posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.